Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 36% —
Register , to see more distinctive signs of diseases and studies — 100%
pheochromocytoma
27%
—
trophoblastic tumors —
93%
high risk of prostate cancer
19%
—
trophoblastic disease —
93%
insulinoma
16%
—
hemangioma —
66%
there is a lot of oncology in the family
16%
—
polyhydramnios during pregnancy —
57%
tumors of the parathyroid glands
16%
—
rare fetal movements —
55%
lee-fraumeni syndrome
15%
—
giant pigmented nevus —
55%
eosinopenia
15%
—
fetal hypoxia —
52%
facial hair growth
14%
—
mom oncology —
52%
anything night sweating in men
14%
—
female pelvic organs —
51%
hyperaldosteronism
13%
—
frequent fetal movements —
50%
itsenko-cushing syndrome (hypercorticism)
13%
—
the only artery of the umbilical cord —
50%
prostate cancer
13%
—
pregnancy —
47%
night sweating
12%
—
ovarian teratoma —
47%
benign epithelial tumors
12%
—
solid tumors
11%
57%
impaired prostate function
12%
—
multiple uterine fibroids —
45%
weakness of the muscles of the hands
12%
—
pregnancy complications —
45%
muscle weakness
12%
—
childhood diseases —
45%
excessive sweating at night
12%
—
multiple fibroids —
45%
the pressure is 100 on
12%
—
suffocation —
44%
discomfort in the chest
12%
—
oncology —
43%
pancreatic cancer
12%
—
cancer —
42%
pituitary tumors
12%
—
bubble drift —
41%
oncology relatives
11%
—
increased —
41%
decreased potassium
11%
—
uterine tumor —
39%
weakness in the hands
11%
—
skin fibroma —
39%
thin skin
11%
—
hypoxia —
39%
weakness in the leg muscles
11%
—
complications of childbirth —
39%
consequences of surgery
11%
—
edwards syndrome —
39%
postoperative scars
11%
—
leukemia in children —
39%
effects of radiation
11%
—
ovarian fibroma —
38%
fat deposits
11%
—
metastatic ovarian cancer —
37%
genital neoplasms
10%
—
submucous uterine fibroids —
37%
osteosarcoma
10%
—
impaired uterine function —
36%
weakness in the legs
10%
—
moles all over the body —
36%
history of vein surgery
10%
—
benign ovarian tumors —
36%
cancer in the anamnesis
10%
—
large mole —
36%
fainting
10%
—
teratoma —
36%
increased sugar
10%
—
blood diseases
8%
44%
radiation damage
9%
—
umbilical cord abnormalities —
35%
scarring
9%
—
brown moles —
35%
tachycardia
9%
—
cardiodilation —
35%
sweating is increased
9%
—
enlargement of the heart —
35%
radiation therapy
9%
—
ovarian cancer —
34%
disorders of consciousness
9%
—
legs thick —
34%
oncology in the anamnesis
9%
—
placental abnormalities —
34%
brain tumor
9%
—
smokes —
33%
impaired venous function
8%
—
angiomatosis —
33%
recovery period
8%
—
fetoplacental insufficiency —
32%
hormonal disorders
8%
—
anemia —
32%
headaches
8%
—
melanoma —
32%
number of births increased —
32%
uterine cancer —
32%
uterine fibroids —
32%
brain cancer —
31%
germinogenic tumors —
31%
from eating better —
31%
combined heart defects —
31%
thin child —
31%
conducting an inspection —
30%
electrocoagulation —
30%
lot of moles —
30%
natural childbirth —
30%
up circulatory disorders —
30%
angiopathy —
29%
ovarian tumors —
29%
angioplasty —
29%
lowered
13%
42%
rapid growth —
28%
premature birth —
28%
fibroma —
28%
smoking desire —
28%
drug disease —
28%
hydrocephalus —
27%
skin cancer —
27%
1 pregnancy —
27%
there are no complaints
8%
35%
vascular tumor
13%
40%
hypotrophy —
26%
abortions —
26%
belly enlargement —
26%
skin problems
8%
34%
no children —
25%
large child —
25%
hematoma —
25%
is better in nature —
25%
problems with studying —
25%
appendages of the uterus —
25%
lymphosarcoma —
25%
congenital heart —
25%
neuroblastoma
15%
40%
history of surgery
12%
37%
hemorrhagic diathesis —
24%
height is low —
24%
consequences of childbirth —
24%
high height —
24%
brain tumors in children
16%
40%
thin —
23%
vascular damage —
23%
increased bleeding —
23%
diabetes mellitus
9%
32%
wound —
22%
palpitations
9%
31%
breast sarcoma
14%
36%
bleeding —
21%
heart dysfunction —
21%
impaired arterial function —
20%
patient's condition
7%
27%
breast cancer
11%
29%
breast tumor
11%
28%
cns tumors
11%
28%
leukemia
11%
28%
brain tumors
10%
26%
consequences of taking medications
11%
27%
benign neoplasms
9%
23%
metastases
16%
24%